Study Evaluating Food Effect and QTc in Patients With Advanced Malignancies

Study Evaluating Food Effect and QTc in Patients With Advanced Malignancies
Conditions:   Advanced Malignancies;   Solid Tumor;   Hematological Malignancy
Intervention:   Drug: Pelabresib
Sponsor:   Constellation Pharmaceuticals
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

May 26, 2022Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Comments